The Complete Guide to CDISC Standards Management
Learn how to easily manage and validate against CDISC data standards our complete guide to…
Certara2024 年 10 月 30 日
Certara Announces New Head of Clinical Pharmacology & Translational Medical Group
RADNOR, PA – 2024 年 10 月 30 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 10 月 30 日
Quantitative systems pharmacology model of GITR-mediated T cell dynamics in tumor microenvironment
摘要：T cell interaction in the tumor microenvironment is a key component of immuno-oncology therapy.…
Certara2024 年 10 月 29 日
Early Feasibility Assessment: A Method for Accurately Predicting Biotherapeutic Dosing to Inform Early Drug Discovery Decisions
Early Feasibility Assessment (EFA) can impact early drug discovery decisions such as determining feasibility of…
Certara2024 年 10 月 29 日
Early Feasibility Assessment: An Innovative Approach to Gain Confidence in Therapeutic Discovery
In this webinar Josh Apgar, PhD discusses Early Feasibility Assessment (EFA), a quantitative approach to early…
Certara2024 年 10 月 29 日
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa. — 2024 年 10 月 28 日 -- Certara, Inc. （纳斯达克股票代码：CERT), a global leader in…
Certara2024 年 10 月 28 日
Pharma Exec: MDMA Therapy for Mental Health Conditions
Certara's Dr. Fran Brown, SVP Drug Development Science, is featured in this recent Pharmaceutical Executive…
Certara2024 年 10 月 28 日
Adapting Value Stories for Global Healthcare Markets
Explore how to tailor healthcare value stories to global market access strategies, addressing cultural nuances,…
Certara2024 年 10 月 28 日
How To Respond to Health Authority Questions
Your biotech company has just submitted the marketing application for your first drug product. It’s…
Certara2024 年 10 月 25 日
Certara Establishes Certainty Conference in Europe, Creating Space for Drug Development Leaders to Convene
Clients are invited to join Certara at this two-day event to further explore and connect…
Certara2024 年 10 月 24 日
